Topical hemostat market seen reaching $8.53B by 2030

The topical hemostat market is projected to grow from $5.45 billion in 2025 to $8.53 billion by 2030, driven by more surgeries, new biomaterials and broader adoption in ambulatory and digital surgery settings. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Topical hemostats help surgeons control bleeding faster, improve visibility and reduce blood loss during operations. - The market outlook points to steady demand as surgical volumes rise and healthcare systems adopt more advanced bleeding-control tools. - Growth in this category can affect hospitals, ambulatory surgical centers and medical-device makers serving operating rooms worldwide.

What happened: - The topical hemostat market is projected to rise from $5.45 billion in 2025 to $5.97 billion in 2026. - The market is expected to reach $8.53 billion by 2030. - The forecast implies a 9.5% CAGR from 2025 to 2026 and a 9.3% CAGR through 2030. - The Business Research Company said the outlook reflects broader surgical demand and technology-led product adoption. - Download a free sample of the topical hemostat market report.

The details: - Topical hemostats are medical devices applied directly to bleeding sites during surgery or trauma care. - These products work by forming physical barriers, activating clotting cascades or supporting platelet aggregation and fibrin formation. - Rising surgical procedure volumes remain a major demand driver. - Aging populations are increasing the number of procedures tied to age-related conditions. - In January 2025, Intuitive Surgical reported that general surgery procedures outside the US rose about 35% in 2024 after a 42% increase in 2023. - Colorectal surgeries made up the largest share of that growth. - Demand is also rising for rapid and reliable hemostatic solutions. - Innovations in biomaterials are supporting new product development. - Hospitals are expanding surgical capacity. - Regulatory clearances are helping more hemostatic products reach the market. - Adoption of bioactive and combination hemostats is expected to accelerate. - Integration with AI and digital surgery platforms is part of the forecast growth story. - Expansion of ambulatory surgical centers is adding another growth channel. - Patient-specific hemostatic treatments are becoming more important. - Surgical infrastructure development in emerging regions is also supporting demand. - View the full topical hemostat market report.

Between the lines: - The market story is less about one breakthrough and more about multiple reinforcing trends across surgery, materials science and digital operating-room tools. - North America led the market in 2025 because of advanced healthcare infrastructure and high surgical volumes. - Asia-Pacific is forecast to be the fastest-growing region as surgical demand and healthcare investment expand. - The regional outlook suggests the next wave of growth may come from markets building out operating-room capacity rather than only from mature hospital systems.

What's next: - Continued adoption of combination and bioactive hemostats could broaden use in more complex procedures. - More ambulatory procedures may increase demand for products that work quickly and reliably in shorter-care settings. - Ongoing upgrades to surgical infrastructure in emerging markets should support additional market expansion through 2030. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards and updated graphics.

The bottom line: - Topical hemostats are moving from a niche surgical aid to a larger, faster-growing part of the global medical-device market.